5th Neoantigen Summit Europe

 The 5^th Neoantigen Summit Europe, the definitive industry meeting for uncovering the full potential of neoantigens in creating individualised neoantigen vaccines is returning in person!

From understanding the latest clinical insights to reviewing vaccines post-COVID, our 35+ expert speakers and 3-day agenda developed alongside #Vaccibody, #Gritstonebio, #Targovax, #Vaximm, #Immunetune and #OdimmaTherapeutics will help you advance your pipeline to successfully weaponise neoantigens for anti-tumour treatment.

Join 100+ colleagues and take on the next frontier in neoantigen identification and vaccine manufacturing.

Key speakers include: Agnete Fredriksen, Chief Innovation & Strategy Officer, Nykode Therapeutics | Barbara Loesch, Head of Technology and Innovation, Medigene |Jessica Matta, Co-Founder & Chief Executive Officer & Chief Scientific Officer, Odimma therapeutics | Andrew Allen, CEO, Gritstone bio | Peter Sondermann, CEO, Tacalyx GmbH |Sijme Zeilemaker, Chief Executive Officer, Immunetune

Find out more in the event guide here: https://ter.li/gulg78

Visit the official event website here: https://ter.li/s89k61